Glimepiride, Pioglitazone and Metformin Tablet
|
Generic Name |
Glimepiride, Pioglitazone and Metformin |
|---|---|
|
Strength |
2 mg + 500 mg + 7.5 mg, 1 mg + 500 mg + 15mg, 2 mg + 500 mg + 15 mg |
|
Form |
Tablet |
|
Packaging |
1 X 10 Tablets |
|
Therapeutic use |
Anti Diabetic |
|
Manufacturing Period |
30 to 45 Days |
Available Composition of
| Name | Strength | Therapeutic use | View More |
|---|---|---|---|
| Voglibose and Metformin Tablet | 0.2 mg + 1000 mg, 0.2 mg + 500 mg, 0.3mg + 1000 mg, 0.3 mg + 500 mg | Anti Diabetic | |
| Glimepiride, Pioglitazone and Metformin Tablet | 2 mg + 500 mg + 7.5 mg, 1 mg + 500 mg + 15mg, 2 mg + 500 mg + 15 mg | Anti Diabetic | |
| Glimepiride, Metformin and Voglibose Tablet | 1 mg + 500 mg + 0.2 mg, 2 mg + 500 mg + 0.2 mg | Anti Diabetic | |
| Glimepiride and Metformin Tablet | 1 mg + 500 mg, 2 mg + 500 mg, 4 mg + 500 mg, 4 mg + 1000 mg | Anti Diabetic | |
| Gliclazide and Metformin Tablet | 60 mg + 500 mg, 80 mg + 500 mg | Anti Diabetic | |
| Glibenclamide and Metformin Tablet | 2.5 mg + 500 mg, 5 mg + 500 mg | Anti Diabetic | |
| Empagliflozin and Metformin Tablet | 12.5 mg + 500 mg | Anti Diabetic | |
| Pioglitazone and Metformin HCL Tablet | 15 mg + 500 mg | Anti Diabetic, Type 2 diabetes | |
| Pioglitazone Tablet | 7.5 mg, 15 mg, 30 mg | Anti Diabetic, Type 2 diabetes | |
| Sitagliptin and Metformin Tablet | 50 mg + 1000 mg, 50 mg + 500 mg | Anti Diabetic, Type 2 diabetes | |
| Glimepiride Tablet | 1 mg, 2 mg, 3 mg, 4 mg | Accessories |
Product Description For Glimepiride, Pioglitazone and Metformin Tablet
products details and uses
Glimepiride Pioglitazone and Metformin Tablet Supplier | Manufacturer and Global Exporter in India
Glimepiride Pioglitazone and Metformin Tablet Supplier, as a trusted we are committed to delivering high-quality, WHO-GMP certified medicines to healthcare providers and distributors worldwide. Glimepiride Pioglitazone and Metformin Tablet is a highly effective combination therapy designed for patients with type 2 diabetes mellitus. This tablet combines three active ingredients—Glimepiride, Pioglitazone, and Metformin—to provide comprehensive glycemic control.
About Glimepiride Pioglitazone and Metformin Tablet
This combination tablet leverages the unique mechanisms of its three components. Glimepiride stimulates insulin secretion from pancreatic beta cells, Pioglitazone improves insulin sensitivity in peripheral tissues, and Metformin reduces hepatic glucose production while enhancing insulin activity. Together, they provide a synergistic effect that helps maintain blood sugar levels within a healthy range. As a reputed Glimepiride Pioglitazone and Metformin Tablet Supplier, we ensure that each batch is manufactured under strict quality control standards, making it safe and effective for patients.
Key Benefits and Uses
-
Helps control high blood sugar levels in type 2 diabetes.
-
Reduces HbA1c and fasting blood glucose levels effectively.
-
Improves insulin sensitivity and pancreatic insulin secretion.
-
Helps lower the risk of diabetes-related complications such as neuropathy, retinopathy, and cardiovascular issues.
-
Convenient combination therapy reduces the number of pills a patient needs to take daily.
Being a reliable Glimepiride Pioglitazone and Metformin Tablet Supplier, we provide formulations that meet international standards and are widely recognized by healthcare providers for efficacy and safety.
Dosage and Administration
The dosage of Glimepiride Pioglitazone and Metformin Tablet varies depending on the patient’s condition, age, and blood sugar levels. It should be prescribed and monitored by a qualified healthcare professional. Typically, tablets are taken orally, with meals, to reduce gastrointestinal side effects. As a WHO-GMP certified Glimepiride Pioglitazone and Metformin Tablet Supplier, we offer reliable supply to hospitals, pharmacies, and distributors ensuring uninterrupted availability.
Precautions
-
Always take this medication under medical supervision.
-
Patients with liver, kidney, or heart conditions should consult a doctor before starting treatment.
-
Monitor blood sugar levels regularly to avoid hypoglycemia.
-
Not recommended for patients with type 1 diabetes or diabetic ketoacidosis.
-
Inform your doctor if pregnant, planning pregnancy, or breastfeeding.
As a responsible Glimepiride, Pioglitazone and Metformin Tablet Supplier, we provide detailed product information to ensure safe and effective use by patients and healthcare professionals.
Possible Side Effects
Although generally well tolerated, some patients may experience:
-
Nausea, vomiting, or diarrhea
-
Dizziness or headache
-
Hypoglycemia (low blood sugar)
-
Weight gain due to fluid retention
-
Rare allergic reactions such as rash or swelling
Being a trusted Glimepiride, Pioglitazone and Metformin Tablet Supplier, we emphasize patient education and support to minimize risks and manage any side effects effectively.
Why Choose Us?
-
WHO-GMP certified Glimepiride, Pioglitazone and Metformin Tablet Supplier.
-
Consistent, high-quality formulations trusted by healthcare providers.
-
Reliable global distribution network ensuring timely supply.
-
Competitive pricing with options for bulk orders and third-party manufacturing.
Our commitment as a leading Glimepiride, Pioglitazone and Metformin Tablet Supplier is to enhance diabetes care worldwide by delivering safe, effective, and high-quality combination therapy. Patients and healthcare providers can trust our products for consistent glycemic control and improved quality of life.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Glimepiride, Pioglitazone and Metformin Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.